US 11458171
Engineering stem cells for cancer therapy
granted A61KA61K35/28A61K35/30
Quick answer
US patent 11458171 (Engineering stem cells for cancer therapy) held by China Medical University expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Medical University
- Grant date
- Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K35/28, A61K35/30, A61K35/545, A61P